Mark Cuban Cost Plus Drug Company partners with Scripta Insights
Scripta Insights, the Rx Navigation company that guides self-insured employers, health plans and their members to prescription savings, is collaborating with Mark Cuban Cost Plus Drug Company, PBC (Cost Plus Drugs).
The companies are committed to working together to make prescription drugs more accessible and affordable to patients. The relationship furthers Scripta’s mission to get members The Right Meds at The Best Price.
“Mark Cuban is a serial entrepreneur who shares our mission to shake up the pharmacy benefit market, putting the power of choice in the patient’s hands, under the care of their doctors, for the first time,” said Eric Levin, CEO of Scripta Insights. “Cost Plus Drugs has been making noise with its unprecedented deep discounts, transparent pricing and vertically-integrated supply chain, and we couldn’t be more excited to team up with them to help our clients’ members get The Right Meds at The Best Price.”
Read more: Mark Cuban Cost Plus Drug Company partners with Coherus to offer Humira biosimilar]
“We are excited to work with Scripta Insights to bring lower prescription drug prices to consumers,” said Alex Oshmyansky, CEO of Mark Cuban Cost Plus Drug Company. “Cost Plus Drugs and Scripta Insights share a common goal of providing consumers the lowest possible price for their prescription medications. With Cost Plus Drugs, consumers can be confident they are getting a fair price and the convenience of medication mailed directly to their homes.”
Scripta is working to integrate Cost Plus Drugs’ discounted pricing into its proprietary Med Mapper, adding to its already robust portfolio of savings strategies that help members save money on their out-of-pocket costs. Through its member app and portal, Scripta provides members with Personalized Savings Reports that reveal all their medication options, whether that’s switching to an alternative prescription available through their health plan or a cash pay option like Cost Plus Drugs.
[Read more: Mark Cuban Cost Plus Drug Company partners with EmsanaRx]